The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation
Abstract The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has now reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
bioRxiv.org - (2022) vom: 28. Okt. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ginex, Tiziana [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| doi: |
10.1101/2021.12.05.471263 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI033174709 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI033174709 | ||
| 003 | DE-627 | ||
| 005 | 20230429085151.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211209s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2021.12.05.471263 |2 doi | |
| 035 | |a (DE-627)XBI033174709 | ||
| 035 | |a (biorXiv)10.1101/2021.12.05.471263 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ginex, Tiziana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has now reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Marco-Marín, Clara |e verfasserin |4 aut | |
| 700 | 1 | |a Wieczór, Miłosz |e verfasserin |4 aut | |
| 700 | 1 | |a Mata, Carlos P. |e verfasserin |4 aut | |
| 700 | 1 | |a Krieger, James |e verfasserin |4 aut | |
| 700 | 1 | |a López-Redondo, Maria Luisa |e verfasserin |4 aut | |
| 700 | 1 | |a Francés-Gómez, Clara |e verfasserin |4 aut | |
| 700 | 1 | |a Ruiz-Rodriguez, Paula |e verfasserin |4 aut | |
| 700 | 1 | |a Melero, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez-Sorzano, Carlos Óscar |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Gougeard, Nadine |e verfasserin |4 aut | |
| 700 | 1 | |a Forcada-Nadal, Alicia |e verfasserin |4 aut | |
| 700 | 1 | |a Zamora-Caballero, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Gozalbo-Rovira, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Sanz-Frasquet, Carla |e verfasserin |4 aut | |
| 700 | 1 | |a Bravo, Jeronimo |e verfasserin |4 aut | |
| 700 | 1 | |a Rubio, Vicente |e verfasserin |4 aut | |
| 700 | 1 | |a Marina, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Geller, Ron |e verfasserin |4 aut | |
| 700 | 1 | |a Comas, Iñaki |e verfasserin |4 aut | |
| 700 | 1 | |a Gil, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Coscolla, Mireia |e verfasserin |4 aut | |
| 700 | 1 | |a Orozco, Modesto |e verfasserin |4 aut | |
| 700 | 1 | |a Llácer, José Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Carazo, José-Maria |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2022) vom: 28. Okt. |
| 773 | 1 | 8 | |g year:2022 |g day:28 |g month:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1371/journal.ppat.1010631 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.12.05.471263 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 28 |c 10 | ||